G-Protein Coupled Receptors (GPCRs) - Global Strategic Business Report

Report
359 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 1227782

Global G-Protein Coupled Receptors (GPCRs) Market to Reach $4.7 Billion by 2030

The global market for G-Protein Coupled Receptors (GPCRs) estimated at US$3.1 Billion in the year 2023, is projected to reach a revised size of US$4.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030.

Cell Lines, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Detection Kits segment is estimated at 5.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 7.7% CAGR

The G-Protein Coupled Receptors (GPCRs) market in the U.S. is estimated at US$1.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$416.9 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

Exciting New Report Features

Full access to influencer engagement stats
Free access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
Complimentary report updates for one year
Competitor coverage with global market shares of major players
Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 52 Featured)

Merck KGaA
BD Biosciences
Enzo Life Sciences, Inc.
Lexicon Pharmaceuticals, Inc.
Molecular Devices LLC
Aragen Life Sciences Pvt. Ltd.
Axxam SpA
Abcam PLC
Eurofins Scientific SE
HD Biosciences Co., Ltd.
Addex Therapeutics
Multispan, Inc.
Creative Biolabs
Beacon Discovery
Distributed Bio

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
G-Protein Coupled Receptors (GPCRs) - Global Key Competitors Percentage Market Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
GPCR: An Introduction
Important Role of GPCRs in Drug Discovery
Popular Types of GPCRs of Therapeutic Interest
Classification of GPCRs
Orphan GPCRs: A Promising Area for Drug Discovery
GPCR Signaling Pathways
Physiological Roles Performed by GPCRs
Outlook
Geographic Market Analysis
Challenges
Competition
Recent Market Activity
World Brands

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Therapeutic Potential of GPCRs Gains Wide Recognition
Allosteric Modulators and Implication of Allostery in Drug Discovery
GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL, IUPHAR, and The DrugBank
GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL
GPCRs Registered as Targets for Approved Drugs with International Union of Basic and Clinical Pharmacology (IUPHAR)
GPCRs Registered as Targets for Approved Drugs with The DrugBank
Hurdles Faced…
Developments in Structural Biology and Receptor Pharmacology Offer Novel Opportunities to GPCR Drug Discovery
In Silico Approaches Underway for GPCR Drug Screening
Microfluidic Cell Technology Holds Potential
Pipeline GPCR Drug Candidates Widen Prospects
Select GPCR Small Molecule Drugs in Active Clinical Development
GPCR Ligands (Agonist) in Phase III Clinical Development
GPCR Ligands (Antagonist) in Phase III Clinical Development
New Indications to Aid Growth
CRISPR Holds Potential to Speed Up GPCR-based Drug Discovery
GPCR-targeted Drugs and Role in Cancer Treatment
Select FDA Approved Drugs and Antibodies against Various Cancer Types
Potential GPCR targets for Cancer Treatment
Anti GPCRs Drugs and Antibodies under Clinical Trials
Rising Incidence of Cancer to Drive Drives Opportunities
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
GPCRs Evolve as Important targets for developing novel therapeutics for Neurodegerative Disorders
Number of Individuals Suffering from Alzheimer's in the US: 2020 and 2025
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
GPCRs: An Important Target for Cardiovascular Drugs
Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
GPCR Screening and Targeting Technologies

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 3: World 15-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 6: World 15-Year Perspective for Cell Lines by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 9: World 15-Year Perspective for Detection Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 11: World Historic Review for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 12: World 15-Year Perspective for Cell Culture Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World Historic Review for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 15: World 15-Year Perspective for Ligands by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 16: World Recent Past, Current & Future Analysis for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 17: World Historic Review for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 18: World 15-Year Perspective for cAMP Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 19: World Recent Past, Current & Future Analysis for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 20: World Historic Review for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 21: World 15-Year Perspective for Calcium Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 22: World Recent Past, Current & Future Analysis for ß-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 23: World Historic Review for ß-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 24: World 15-Year Perspective for ß-Arrestin Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 25: World Recent Past, Current & Future Analysis for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 26: World Historic Review for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 27: World 15-Year Perspective for Radioligand Binding & GTPyS Functional Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 28: World Recent Past, Current & Future Analysis for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 29: World Historic Review for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 30: World 15-Year Perspective for Internalization Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 31: World Recent Past, Current & Future Analysis for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 32: World Historic Review for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 33: World 15-Year Perspective for Other Assay Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 34: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 35: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 36: World 15-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 37: World Recent Past, Current & Future Analysis for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 38: World Historic Review for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 39: World 15-Year Perspective for Metabolic Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 40: World Recent Past, Current & Future Analysis for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 41: World Historic Review for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 42: World 15-Year Perspective for Inflammation Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 43: World Recent Past, Current & Future Analysis for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 44: World Historic Review for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 45: World 15-Year Perspective for CNS Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 46: World Recent Past, Current & Future Analysis for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 47: World Historic Review for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 48: World 15-Year Perspective for Respiratory Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 49: World Recent Past, Current & Future Analysis for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 50: World Historic Review for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 51: World 15-Year Perspective for Cardiovascular Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 52: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 53: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2022 and % CAGR
Table 54: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2024 & 2030
Table 55: World G-Protein Coupled Receptors (GPCRs) Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

UNITED STATES

G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)

CANADA

JAPAN

G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)

CHINA

G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)

EUROPE

G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)

FRANCE

G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)

GERMANY

G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)

ITALY

UNITED KINGDOM

G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)

REST OF EUROPE

ASIA-PACIFIC

G-Protein Coupled Receptors (GPCRs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)

REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Merck KGaA
BD Biosciences
Enzo Life Sciences, Inc.
Lexicon Pharmaceuticals, Inc.
Molecular Devices LLC
Aragen Life Sciences Pvt. Ltd.
Axxam SpA
Abcam PLC
Eurofins Scientific SE
HD Biosciences Co., Ltd.
Addex Therapeutics
Multispan, Inc.
Creative Biolabs
Beacon Discovery
Distributed Bio

Table Information

Report Attribute	Details
No. of Pages	359
Published	April 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 3.1 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.7 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5269EUR$5,450USD£4,528GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10010EUR$10,355USD£8,604GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15806EUR$16,350USD£13,585GBP

Global G-Protein Coupled Receptors (GPCRs) Market to Reach $4.7 Billion by 2030

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 7.7% CAGR

Exciting New Report Features

What to Expect from the Global Economy in 2024

Select Competitors (Total 52 Featured)

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Global G-Protein Coupled Receptors (GPCRs) Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

Global G-Protein Coupled Receptors (GPCR) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

G-Protein Coupled Receptors Market by Product, Assay Type, Application, and Region 2024-2032

G-Protein Coupled Receptors Global Market Report 2024

Global G-Protein Coupled Receptors Market Report and Forecast 2024-2032